Detalhe da pesquisa
1.
De Novo Malignancies Screening After Liver Transplantation for Alcoholic Liver Disease: A Comparative Opportunistic Study.
Liver Transpl
; 24(12): 1690-1698, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207421
2.
Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
Liver Transpl
; 24(10): 1425-1436, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30021061
3.
Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).
J Gastroenterol Hepatol
; 28(2): 329-34, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23190183
4.
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).
Gastroenterology
; 141(1): 119-27, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21439960
5.
Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver.
Liver Int
; 32(10): 1477-92, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22891751
6.
Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).
J Med Virol
; 82(12): 2027-31, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20981789
7.
Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin.
J Med Virol
; 82(5): 747-54, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20336715
8.
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.
Clin Res Hepatol Gastroenterol
; 42(4): 313-318, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551607
9.
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
Lancet Gastroenterol Hepatol
; 2(3): 177-188, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404133
10.
Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection.
PLoS One
; 11(6): e0156200, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27281019
11.
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
PLoS One
; 11(6): e0158297, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27348813
12.
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
PLoS One
; 10(9): e0138091, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26394142
13.
Performance of an antigen-antibody combined assay for hepatitis C virus testing without venipuncture.
J Clin Virol
; 55(3): 220-5, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22901327
14.
Clinically related protein-peptide interactions monitored in real time on novel peptide chips by surface plasmon resonance imaging.
Clin Chem
; 52(2): 255-62, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16339301